Skip to main content
. Author manuscript; available in PMC: 2010 Dec 6.
Published in final edited form as: Analyst. 2010 Jul 8;135(10):2496–2511. doi: 10.1039/c0an00204f

Table 2.

Selected examples of SPR-based detection of cancer biomarkers

Biomarker Amplification Assay type DL Ref.
VEGF Precipitation RNA–aptamer microarrays 45 pg mL−1 53
PSA Au-NP Ab1/PSA/Ab2–biotin/streptavidin–AuNP 1 ng mL−1 75
p53 None SPR binding assay 0.2–0.5 ng mL−1 76
IL-6 None Protein A/Ab1/IL6/IL6 receptor 3.75 ng mL−1 77
IL-8 None Ab1/IL8/Ab2 <2 ng mL−1 78
PSA DNA barcode Ab1–NP/Ab2–magnetic microparticles 30 aM PSA 79